MarketInOut Stock Screener Log In | Sign Up
 

OS Therapies Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/23/2026
OS Therapies Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization58.51 mln
Float43.74 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

8.50
Transformational upside

Relative Strength

10 / 100
Significantly lagging

ROE

683
Extraordinary

ROA

-455
Deeply negative

Business Description

OS Therapies is a Maryland-based medical company working to develop new treatments for bone cancer and other solid tumors. Its main focus is on two promising therapies: an immune-based treatment for osteosarcoma that is ready to use without customization, and a targeted drug delivery technology designed to release medication more precisely within the body. Founded in 2018, the company is still in the clinical development phase and operates primarily in the United States.

Key Fundamentals

EPS-1.08
ROE683
ROIC-525
ROA-455
Interest Cover-465
EBITDA, mln-38.79
EV / EBITDA-1.93
EV / EBIT-1.90

Quote Details

Last 1.25
Change 0 (0%)
Open 1.27
Volume 141,925
Turnover 177,406
Average Volume 681,720

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price8.50
Short Ratio3.57
Short % of Float5.95

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.3% 16 / 100   
1 Month -24.7% 15 / 100   
2 Months -17.22% 25 / 100   
6 Months -29.38% 21 / 100   
1 Year -31.69% 25 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog